Hyperion Defi (HYPD) Capital Expenditures (2017 - 2024)
Hyperion Defi (HYPD) posted quarterly Capital Expenditures of $1.0 for Q4 2024, down 100.0% year-over-year from $145231.0 in Q1 2024, and down 99.94% quarter-over-quarter from $1623.0 in Q3 2024.
Hyperion Defi (HYPD) Capital Expenditures (2017 - 2024) Analysis & Trends
Hyperion Defi (HYPD) has reported Capital Expenditures for 8 consecutive years, with $1.0 the latest figure, recorded in Q4 2024.
- In Q4 2024, Capital Expenditures fell 100.0% year-over-year to $1.0; the TTM figure through Dec 2024 stood at $161477.0 (down 94.33% YoY), while the FY2024 annual figure was $161477.0, down 94.33% from the prior year.
- Capital Expenditures slipped to $1.0 in Q4 2024 per HYPD's latest filing, from $1623.0 in the prior quarter.
- Across five years, Capital Expenditures topped out at $1.2 million in Q2 2023 and bottomed at $1.0 in Q4 2024.
- Historically, Capital Expenditures has averaged $251863.1 across 5 years, with a median of $110440.0 in 2022.
- Annual changes were most pronounced in 2023 — Capital Expenditures surged 1025.11% — and 2024, when it sank 100.0%.
- Hyperion Defi's Capital Expenditures stood at $59211.0 in 2020, then gained by 3.88% to $61510.0 in 2021, then sank by 49.62% to $30990.0 in 2022, then jumped by 368.64% to $145231.0 in 2023, then tumbled by 100.0% to $1.0 in 2024.
- Business Quant data shows HYPD's Capital Expenditures at $1.0 in Q4 2024, $1623.0 in Q3 2024, and $45748.0 in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.66 Bn | 131.80 Bn | 2.84 Bn | 112.20 Mn |
| 2 | Regeneron Pharmaceuticals | 86.52 Bn | 78.53 Bn | 3.93 Bn | 240.20 Mn |
| 3 | Argenx Se | 65.33 Bn | 60.14 Bn | 1.37 Bn | - |
| 4 | Moderna | 59.76 Bn | 54.62 Bn | 52.00 Mn | 37.00 Mn |
| 5 | BeOne Medicines | 42.15 Bn | 37.05 Bn | 1.53 Bn | 25.02 Mn |
| 6 | Alnylam Pharmaceuticals | 31.84 Bn | 28.53 Bn | 992.69 Mn | 34.68 Mn |
| 7 | BioNTech SE | 28.23 Bn | 9.84 Bn | 668.28 Mn | -73.57 Mn |
| 8 | Insmed | 27.52 Bn | 26.36 Bn | 358.27 Mn | 6.26 Mn |
| 9 | Royalty Pharma | 27.29 Bn | 26.46 Bn | - | 251.02 Mn |
| 10 | Hyperion Defi | 46.21 Mn | 36.57 Mn | 357,693.00 | 7.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 1.00 |
| Dec 31, 2024 | 1.00 |
| Sep 30, 2024 | 1,623.00 |
| Sep 30, 2024 | 1,623.00 |
| Jun 30, 2024 | 45,748.00 |
| Jun 30, 2024 | 45,748.00 |
| Mar 31, 2024 | 114,105.00 |
| Mar 31, 2024 | 114,105.00 |
| Dec 31, 2023 | 145,231.00 |
| Dec 31, 2023 | 145,231.00 |
| Sep 30, 2023 | 580,164.00 |
| Sep 30, 2023 | 580,164.00 |
| Jun 30, 2023 | 1.20 Mn |
| Jun 30, 2023 | 1.20 Mn |
| Mar 31, 2023 | 920,865.00 |
| Mar 31, 2023 | 920,865.00 |
| Dec 31, 2022 | 30,990.00 |
| Dec 31, 2022 | 30,990.00 |
| Sep 30, 2022 | 228,028.00 |
| Sep 30, 2022 | 228,028.00 |